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Objectives. This study sought to determine the incidence and
extent of dobutamine-induced contractile reserve in myocardial
regions characterized by classical and new positron emission
tomographic (PET) patterns in patients with chronic ischemic left
ventricular dysfunction.
Background. PET is considered the most accurate method for
assessment of myocardial viability, which is traditionally identi-
fied by perfusion–metabolism mismatch.
Methods. In 23 patients, segmental wall thickening expressed
by four echocardiographic scores at rest and during low dose (5
and 10 mg/kg body weight per min) dobutamine infusion and
regional myocardial uptake of potassium-38 and fluorine-18 flu-
orodeoxyglucose (F-18 FDG) during glucose clamp were compared
in 16 corresponding segments.
Results. Of a total of 368 segments, data analysis focused on
214 (58%) dyssynergic segments at baseline. Contractile reserve
was identified with increasing incidence according to the six
following PET patterns: 1) diminished perfusion and moderate
reduction of F-18 FDG uptake (3 [11%] of 28 segments); 2)
proportional reduction of perfusion and F-18 FDG uptake (10
[23%] of 43 segments); 3) perfusion–metabolism mismatch (19
[46%] of 41 segments); 4) preserved perfusion but moderate
reduction of F-18 FDG uptake (13 [46%] of 27 segments); 5)
preserved perfusion and F-18 FDG uptake (37 [59%] of 63
segments) compared with our normal database; and 6) normal
perfusion but absolute increased F-18 FDG uptake (8 [73%] of 11
segments). In the latter category, only 7 of 24 segments had
normal rest function. In dyssynergic segments with F-18 FDG
uptake >250% supplied by vessels with >275% stenosis, improve-
ment in contractility during dobutamine correlated with the
presence of collateral channels.
Conclusions. Myocardial regions with the traditional mismatch
pattern of viability show contractile reserve in slightly <50%. In
segments with moderate reduction of F-18 FDG uptake, the
contractile response to dobutamine is linked to the level of rest
perfusion. Most segments with preserved perfusion and increased
F-18 FDG uptake have impaired rest function, but contractile
reserve is still present. These data suggest that in chronic
ischemic left ventricular dysfunction, myocardial hibernation is a
heterogeneous condition.
(J Am Coll Cardiol 1997;30:1651–9)
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Distinguishing between necrotic tissue and noncontractile but
salvageable myocardium has important implications for clinical
decision making in patients with chronic coronary artery
disease (CAD) and left ventricular dysfunction (1). This ques-
tion may be trivial if angina is the main symptom and when left
ventricular dysfunction is only moderate but is crucial in
patients who present with severe ischemic left ventricular
dysfunction. In most of these patients, asynergic myocardium
may correspond to an admixture of areas in different states—
scar, ischemia, stunning or hibernation (2). Several imaging
techniques are increasingly used for assessing perfusion, mem-
brane integrity, oxidative or anaerobic metabolism and con-
tractile reserve (3), but there is no imaging procedure that can
serve as a reference standard.
Several recent studies have suggested that low dose dobut-
amine echocardiography should be the preferred imaging
technique for preoperative assessment of patients with severe
chronic ventricular dysfunction because the presence of con-
tractile reserve is highly predictive of early—within 1 to 3
months—improvement after revascularization (4,5). In con-
trast, thallium-201 single-photon emission computed tomogra-
phy (SPECT) overestimates the probability of early recovery.
This is not surprising because thallium-201 uptake requires
only membrane integrity, whereas an inotropic response to
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dobutamine requires preserved contractile material and thus a
higher degree of myocyte functional integrity (6). Metabolic
imaging with PET has been considered the most accurate
method for identifying myocardial viability (7). Regions with
a mismatch pattern—reduced perfusion but preserved
fluorine-18 fluorodeoxyglose (F-18 FDG) uptake—contain
predominantly viable cells and seem more likely to recover
their contractile function after revascularization (8,9).
Myocardial regions with concordant reduction of perfusion
and glucose utilization are considered to represent nonviable
myocardium. Myocardial regions exhibiting normal perfusion
are usually considered normal regardless of the extent of
glucose utilization. Functional characteristics of segments with
normal perfusion and increased F-18 FDG uptake are un-
known. Only one study (10) has assessed the clinical signifi-
cance of a moderate reduction in regional myocardial glucose
utilization in regions with normal perfusion.
In the present study, consecutive patients with chronic
CAD and heart failure or severe left ventricular dysfunction
underwent both PET and low dose dobutamine echocardiog-
raphy to evaluate the proportion of remaining viable tissue and
possible indication for bypass surgery. The aims were the
following: 1) to study the relation between semiquantitative
measurements of regional perfusion, regional glucose utiliza-
tion and corresponding echocardiographic scores of myocar-
dial thickening at baseline and during low dose dobutamine
infusion; and 2) to determine the absence and presence and,
when present, the extent of contractile reserve in regions
characterized by various patterns of combined perfusion and
glucose utilization.
Methods
Study patients. The study included 23 patients with angio-
graphically proved severe CAD and profound alteration of left
ventricular function (22 men, 1 woman; 39 to 73 years old,
mean [6SD] age 61 6 9). Mean left ventricular ejection
fraction determined by ventriculography was 29 6 9%. Sixteen
patients had three-vessel disease; five had two-vessel disease;
and two had one-vessel disease. Fifty-eight percent of diseased
vessels were occluded. Sixteen patients had had a previous
myocardial infarction; two had had two infarctions; and one an
episode of unstable angina, but not within 3 weeks of the study.
Ten patients had stable angina; 18 had heart failure (New York
Heart Association functional class III or IV). PET and low
dose dobutamine echocardiography were performed within 1
week in patients with stable chronic CAD. All patients gave
written informed consent, and the study was approved by our
hospital ethics committee.
Dobutamine stress echocardiography. Echographic exami-
nation. Each patient underwent low dose dobutamine echo-
cardiography. If a patient was treated by a beta-adrenergic
blocking agent, the drug was stopped 48 h before the test.
Two-dimensional transthoracic echocardiograms were ob-
tained in standard views with the patient lying at rest in the left
lateral position. Dobutamine was infused intravenously at
5 mg/kg body weight per min, followed by 10 mg/kg per min,
each stage lasting for 3 min. The echocardiogram was obtained
continuously and intermittently recorded on videotape, at least
during the last minute of each stage. Digital acquisition of
images was obtained at rest, at every dobutamine dose and
during recovery for side by side display in quad screen format.
A 12-lead electrocardiogram was monitored continuously and
recorded every minute. Blood pressure was measured at each
stage by sphygmomanometer.
Analysis of echocardiograms. The dobutamine echocardio-
graphic studies were interpreted by two experienced observers
(L.A.P., J.L.P.) who had no knowledge of the clinical, angio-
graphic and PET findings. The analysis was semiquantitative,
and the classical 16-segment model was used. Wall thickening
of each segment was scored by a four-point scoring system: 1 5
normal wall thickening; 2 5 moderate hypokinesia; 3 5 severe
hypokinesia; and 4 5 akinesia or dyskinesia. We decided to
merge akinesia and dyskinesia in the only score of four for the
following reasons. The echocardiographic pattern of an aki-
netic segment at rest becoming dyskinetic with dobutamine is
related to a mechanical phenomenon (11) and does not
represent ischemia. In contrast, a dyskinetic segment that
would be judged akinetic with low dose dobutamine cannot be
considered as having contractile reserve. We considered a
segment severely hypokinetic in the presence of minimal wall
thickening ,2 mm, confirmed when possible by M-mode
recording.
Rest dyssynergy was defined as severe segmental dysfunc-
tion, with a score of 3 or 4. Contractile reserve was judged to
be present when wall thickening improved during low dose
dobutamine by at least one score. A distinction was made
between a small improvement of only one score and large
improvement of two or more scores. Inadequately visualized
segments were not scored. Discrepancies between observers
were resolved by consensus. The low level of interobserver
variability in our laboratory has been previously documented
(12,13) and may relate to similar reading criteria. However,
variability between expert interinstitutional centers may be
higher (14).
PET. The combined study of regional perfusion and glu-
cose utilization was performed at rest using potassium-38
(K-38) and F-18 FDG, respectively, and the whole-body ECAT
951/31R scanner (CTI). This equipment allows simultaneous
Abbreviations and Acronyms
ANOVA 5 analysis of variance
CAD 5 coronary artery disease
df 5 degrees of freedom
F-18 FDG 5 fluorine-18 fluorodeoxyglucose
K-38 5 potassium-38
PET 5 positron emission tomography
(tomographic)
SPECT 5 single-photon emission computed
tomography (tomographic)
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acquisition of 31 slices 3.4 mm apart. For optimal positioning
of the heart within the field of view, a 5-min transmission scan
was acquired at the beginning of the procedure. It was followed
by a 30-min transmission scan used for a measured attenuation
correction. The emission scans began with a perfusion study
(mean injection of 518 MBq of K-38); next, after the decay of
K-38 (half-life 7.6 min), 370 MBq of F-18 FDG was injected
intravenously. A 20-min static scan was performed after a delay
of 35 to 45 min. To provide optimal definition of the myocar-
dial walls and standardize metabolic conditions, a hyperinsu-
linemic euglycemic clamp was used according to the method of
De Fronzo et al. (15).
K-38 is a cationic positron-emitting tracer that behaves like
thallium-201 and rubidium-82 (16). Intracellular transport of
the tracer is mediated by the sodium–potassium transmembra-
nous ion exchange system. On extraction by the myocardial
cells, the tracer has a prolonged retention time that, with its
rapid blood flow clearance, provides high image quality of the
heart.
Image processing and data analysis. For systematic analysis
of results, transaxial images were reoriented into 12 short-axis
images of the heart using a dedicated SUN work station (SUN
Microsystem Inc.). Reoriented short-axis images served as
input function data in a semiautomated program providing
polar coordinate maps of myocardial tracer uptake. The endo-
cardial and epicardial edges of the myocardium were manually
defined with circles by the operator (P.G.M.). The posterior
intersection of the right and left ventricles was also drawn. A
radius was then automatically interpolated between the center
of the circles and this point of intersection. In each plane, the
radius served as the beginning of a circumferential profile of
activity along to 60 equidistant radii. The program automati-
cally searches for a mean of the maximal activity recorded in a
3 3 3-pixel area along each radius. Regional data were
displayed on a coordinate polar map. The polar map was
subsequently divided in 16 segments corresponding to the
echographic segmentation of the heart used for comparative
analysis. In each patient, the myocardial segment characterized
by the highest number of counts in the perfusion scan was used
as the normal reference segment for that patient. K-38 activity
in all other segments was then expressed as a percentage of the
activity measured in the reference segment. Relative segmental
F-18 FDG uptake was assessed using the identical method,
giving a value of 100% to the reference segment obtained in
the perfusion scan (“normalization” of data).
Reference values. Because reference values for perfusion
and glucose utilization change from one laboratory to another,
we established our normal values in 10 normal subjects with a
low likelihood of CAD. All subjects were studied using a
hyperinsulinemic euglycemic clamp. Data analysis was per-
formed using polar map displays. In this group of control
subjects, the relative segmental activity of K-38 and F-18 FDG
uptake averaged 84 6 10% and 93 6 9%, respectively. On the
basis of these data, perfusion and glucose utilization were
considered abnormal if values fell outside 2 SD of the mean
relative segmental tracer activity measured in our control
group: The thresholds values were 64% for perfusion and 75%
for glucose utilization.
Patterns of perfusion and glucose utilization: criteria of viabil-
ity. For the purpose of data analysis, the myocardial segments
were separated into six different categories. The first three
were characterized by reduced perfusion and increasing levels
of F-18 FDG activity, whereas in the last three, the perfusion
was within normal limits, and F-18 FDG uptake increased from
category to category. Table 1 summarizes this classification.
With PET, a dyssynergic segment was considered viable in
the presence of F-18 FDG uptake $50%. With echocardiog-
raphy, a dyssynergic segment was considered viable when the
score at rest was #3, with improvement of contractility by at
least one score during dobutamine infusion.
Statistical analysis. Results are expressed as mean value 6
SD. In a recent study that compared the patterns of perfusion
and metabolism in dobutamine-responsive myocardium,
Sawada et al. (17) verified that a segment by segment analysis
of the data was appropriate in the absence of any consistent
intrapatient correlation of the segment data. Because our
analysis was similar to that performed by Sawada et al. (17), we
also used the segment as the unit of analysis. Differences in
K-38 and F-18 FDG uptake between groups of segments were
compared by analysis of variance (ANOVA), followed by the
Bonferroni modified t test when significant differences were
indicated by ANOVA. The chi-square test was used to com-
pare proportions between categories; p , 0.05 was considered
statistically significant.
Results
Patients. Table 2 presents clinical characteristics of the
patients and summarizes the overall results of the two tech-
niques used to detect myocardial viability. Patients had a mean
follow-up period of 48 6 8 months after PET and dobutamine
echocardiography. According to PET, an admixture of viable
and necrotic myocardium was observed in 13 patients; viability
alone was present in 9 and necrosis alone in 1. Low dose
dobutamine echocardiography showed the presence of viable
tissue alone in 1 patient and necrosis alone in 4; 18 patients
Table 1. Categories of Perfusion and Uptake Patterns
Category Pattern
K-38
Uptake F-18 FDG Uptake
1 “Necrotic pattern” ,64% ,50%
2 Reduced perfusion and
moderately reduced
F-18 FDG uptake
,64% Between 50% and 75%
3 “Mismatch pattern” ,64% .75%
4 Normal perfusion and
moderately reduced
F-18 FDG uptake
$64% Between 50% and 75%
5 “Normal pattern” $64% Between 75% and 111%
6 Normal perfusion and high
F-18 FDG uptake
$64% .111%
F-18 FDG 5 fluorine-18 fluorodeoxyglose; K-38 5 potassium-38.
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had both viable and necrotic myocardium. PET and dobut-
amine echocardiography yielded concordant identification of
viability or necrosis in 20 patients (87%).
Surgical revascularization was performed in nine patients
with viable myocardium detected by both PET and dobut-
amine echocardiography and in one patient with viable tissue
demonstrated by dobutamine echocardiography only. During
follow-up, cardiac death was registered in four medically
treated patients who had viable myocardium demonstrated by
PET and dobutamine echocardiography.
Distribution of perfusion and F-18 FDG uptake in dyssyn-
ergic segments. Of 368 segments, 323 were correctly imaged
for comparative PET and echographic data analysis. Two
hundred fourteen segments (66%) had severe rest dyssynergy
(echographic score 3 or 4); 43 (20%) were identified as
“necrotic” (category 1); reduced perfusion with moderate
reduction of F-18 FDG uptake was observed in 29 (14%)
(category 2); 41 (19%) had the “mismatch pattern” (category
3); 27 (13%) showed normal perfusion with moderately re-
duced F-18 FDG uptake (category 4); 63 (29%) were classified
as “normal” (category 5); and 11 (5%) showed normal perfu-
sion with high F-18 FDG uptake (category 6).
Segmental perfusion and F-18 FDG uptake versus contrac-
tile response during low dose dobutamine infusion. Among
the 214 dyssynergic segments at baseline, 118 (55%) did not
have improved contractility during a low dose dobutamine
infusion. Improvement of contractility by one echographic
score was observed in 21 dyssynergic segments (10%) and by
two or more scores in 75 (35%). As shown in Figure 1,
perfusion, as assessed by K-38 uptake, was significantly higher
(p , 0.001) in dyssynergic segments with improvement in
contractility by at least one score during dobutamine than
in those without contractile reserve. No significant difference
in perfusion level was documented between segments that had
improved contractility by one and two or more scores. When
F-18 FDG uptake was related to the presence and extent of
contractile reserve, there was a significant difference in tracer
uptake between nonresponsive segments and segments with
improved contractility by at least two scores during low dose
dobutamine infusion only. As shown in Figure 2, the propor-
tion of dyssynergic segments that showed a positive inotropic
response to dobutamine increased with the level of regional
perfusion (chi-square 44.7, degrees of freedom (df) 3, p ,
0.001) or F-18 FDG uptake (chi-square 4 5.3, df 3, p , 0.001).
One-fifth of dyssynergic segments with severe reduction of
perfusion or F-18 FDG uptake (tracer uptake ,50%) had
contractile reserve, whereas one-third of segments with mod-
erately reduced perfusion (between 50% and 63%) or F-18
FDG uptake (between 50% and 75%) demonstrated a positive
response to dobutamine. When perfusion or F-18 FDG uptake



















1 69/M 23 2 8 1 7 1 7 CABG; alive, no improvement of
LV function
2 67/M 34 3 8 1 8 1 2 CABG; alive, no symptoms
3 45/M 37 3 7 1 7 1 7 CABG; alive, no symptoms
4 59/M 23 3 9 2 0 2 0 Tx; excellent outcome
5 54/F 33 2 11 1 11 1 6 Cardiac death before scheduled
CABG
6 63/M 23 3 7 1 2 1 4 CABG; cardiac death
7 39/M 19 3 9 1 9 1 8 Medical therapy; cardiac death
8 67/M 17 3 9 1 6 1 1 Medical therapy; noncardiac death
9 73/M 24 3 9 1 9 1 2 Medical therapy; cardiac death
10 70/M 26 2 7 1 4 1 2 CABG; noncardiac death
11 47/M 40 2 9 1 9 1 7 CABG; alive, no symptoms
12 55/M 47 3 8 1 8 1 2 Medical therapy; cardiac death
13 48/M 15 3 10 1 10 1 8 CABG; alive, no symptoms
14 55/M 14 3 13 1 8 1 4 CABG; alive no symptoms
15 64/M 24 3 11 1 5 2 0 Medical therapy; cardiac death
16 70/M 34 3 7 1 6 2 0 Medical therapy; alive
17 55/M 31 3 11 1 11 1 8 Medical therapy; cardiac death
18 61/M 36 3 12 1 10 1 8 CABG; alive, no symptoms
19 63/M 17 3 10 1 8 1 2 CABG; alive, alteration of LV
function
20 68/M 27 1 12 1 11 1 9 Medical therapy; noncardiac death
21 67/M 32 3 9 1 7 1 4 Medical therapy; alive
22 69/M 38 2 10 1 7 1 2 Medical therapy; alive
23 69/M 43 1 6 1 2 2 0 Medical therapy; alive
CABG 5 coronary artery bypass graft surgery; Echo 5 dobutamine echocardiography; F 5 female; LV 5 left ventricular; LVEF 5 left ventricular ejection fraction;
M 5 male; PET 5 positron emission tomography; Pt 5 patient; segs 5 segments; Tx 5 transplantation; 1 5 present; 2 5 absent.
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was within normal limits, 60% of dyssynergic segments had
contractile reserve.
Contractile reserve in six categories of perfusion and F-18
FDG uptake. As shown in Figure 3, the majority of segments
(33 [77%] of 43) considered necrotic by PET (category 1)
showed no decrease in myocardial thickening during low dose
dobutamine infusion. In categories characterized by moder-
ately reduced F-18 FDG uptake, the response to dobutamine
depended on the level of segmental perfusion. Reduction of
perfusion with moderately reduced F-18 FDG uptake (catego-
ry 2) was associated with contractile reserve in only 11% of
segments, whereas preserved perfusion with moderate reduc-
tion of F-18 FDG uptake (category 4) was associated with the
presence of contractile reserve in 48% of segments (p , 0.05).
Nineteen (46%) of 41 segments with a mismatch pattern
(category 3) had increased wall thickening during dobutamine
infusion. The largest number of segments (37 of 214) respond-
ing to dobutamine administration had normal perfusion and
F-18 FDG uptake (category 5). The highest proportion of
segments with contractile reserve (73%) was observed in
segments characterized by normal perfusion and high F-18
FDG uptake (category 6).
Changes in contractile score during low dose dobutamine
test in segments with a mismatch pattern (category 3). Figure
4 presents the contractile score change for each segment with
a perfusion–metabolism mismatch during low dose dobut-
amine infusion. Only 3 segments with a mismatch pattern had
normal rest wall thickening (score 1), whereas 41 were dyssyn-
ergic (score $3). The response to low dose dobutamine
infusion was markedly heterogeneous among these dyssynergic
segments. With dobutamine, 5 segments (12%) normalized
their contractility (score 1); 12 (30%) became moderately
hypokinetic (score 2); and 24 (58%) remained dyssynergic
(score $3).
Changes in contractile score during low dose dobutamine
test in segments with normal perfusion and high F-18 FDG
uptake (category 6). Figure 5 presents the contractile score
change for each segment in category 6 during low dose
dobutamine infusion. Of the 24 segments that presented with
normal perfusion and high F-18 FDG uptake, only 7 (29%)
had normal rest wall thickening (score 1); 6 were moderately
hypokinetic (score 2); and 11 (46%) were dyssynergic (score
$3). With dobutamine, 8 (73%) of the dyssynergic segments
showed the presence of contractile reserve either by normal-
izing myocardial wall thickening (5 segments) or by a change to
moderate hypokinesia (3 segments). Only three segments
remained dyssynergic (score $3).
Correlation between PET and echocardiographic patterns
with angiographic data. In the presence of severe coronary
artery stenosis ($75%), detection of viability by low dose
dobutamine echocardiography in dyssynergic segments with
F-18 FDG evidence of viability (F-18 FDG uptake $50%)
depended on the presence of collateral channels. Indeed, 44
(86%) of 51 dyssynergic segments viable according to PET that
did not have improved contractility during low dose dobut-
amine were supplied by a severely stenosed artery without
collateral vessels. Conversely, in the presence of severe coro-
nary stenosis with collateral vessels, 44 (78%) of 56 dyssynergic
segments with PET evidence of viability had improved con-
tractility during dobutamine infusion.
Figure 1. K-38 (left) and F-18 FDG (right)
uptake (mean value 6 SD) in dyssynergic seg-
ments versus change in echocardiographic
score with low dose dobutamine.
Figure 2. Relation between the proportion of
dyssynergic segments with contractile reserve
and the level of perfusion (left [K-38]) or F-18
FDG (right) uptake.
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Discussion
The main findings of this study are that 1) contractile reserve
is observed in ,50% of segments showing a mismatch between
perfusion and glucose utilization, a pattern considered reliable
as a sign of viability; 2) the contractility of most segments with
preserved perfusion and increased glucose utilization is im-
paired in basal conditions but improves during inotropic
stimulation; 3) the functional significance of myocardial re-
gions with moderately reduced glucose utilization depends on
the level of rest blood flow; 4) dobutamine-induced contractile
reserve may be observed in the presence of several patterns of
perfusion and glucose utilization, most probably corresponding
to different myocardial states, such as stunning and hiberna-
tion, associated with a variable amount of nontransmural
infarction; and 5) in regions perfused by a severely stenosed
vessel, contractile reserve of segments with F-18 FDG evidence
of viability depends on collateral circulation.
Inotropic stimulation of myocardium in the presence of
perfusion metabolic mismatch. Of the 41 dyssynergic seg-
ments with flow–metabolic mismatch, contractile reserve was
present in only 19 (46%). Several reasons may explain why
.50% of such segments remained akinetic throughout dobut-
amine infusion: 1) Some improvement may have occurred but
was too small or too brief to be detectable. 2) Beta-blockers
were withheld before the echocardiographic test but not before
PET. The increase in rest heart rate resulting from beta-
blocker withdrawal determined a new perfusion–contraction
match that could have resulted in a reduced inotropic response
in these myocardial regions (18). 3) The absence of contractile
reserve may be related to morphologic alterations, in particu-
lar, a significant reduction of contractile material. Myocardial
biopsy samples from patients with prolonged reversible con-
tractile dysfunction have indeed demonstrated ultrastructural
changes in myocytes: cellular swelling, abnormalities of the
mitochondria, increased glycogen content and, importantly,
severe reduction in the number of myofibrils (19). Conse-
quently, recruitable contractile reserve cannot be present in
these conditions.
Significance of increased F-18 FDG uptake in regions with
normal perfusion. The significance of a new PET pattern—
abnormally high F-18 FDG uptake in regions with normal rest
blood flow—has not yet been evaluated. This pattern was
found in 24 segments in 13 patients. Only 7 of these 24
segments had normal contractility at rest. In the other 17
segments, mechanical function was impaired in basal condi-
tions, most of them exhibiting contractile reserve. Of the 11
segments with severe dysfunction at rest (score 3 or 4), 8
retained contractile reserve, with an improvement of two
scores in 7 segments during low dose dobutamine infusion.
These imaging characteristics—impaired contractility, pre-
served perfusion at rest and increased glucose utilization—in
patients in stable clinical condition are compatible with me-
chanical and metabolic myocardial adaptation to chronic cor-
onary stenosis. Our findings are similar to those of Liedtke et
al. (20) in an experimental pig model. In their pig model of
partial coronary stenosis for 4 days, regional systolic shortening
decreased by 54% despite maintenance of normal rest coro-
Figure 4. Schematic representation of wall thickening scores at base-
line and during low dose dobutamine infusion for segments showing a
mismatch pattern (category 3).
Figure 5. Schematic representation of wall thickening scores at base-
line and during low dose dobutamine infusion for segments showing
normal perfusion with high F-18 FDG uptake (category 6).
Figure 3. Distribution of segments with (solid portions) and without
(open portions) contractile reserve according to the six categories of
perfusion and F-18 FDG uptake.
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nary flow and myocardial oxygen consumption at aerobic
levels. This was accompanied by altered metabolism: a de-
crease in fatty acid oxidation and a multifold increase in
glycolysis (20). These results can also be compared with the
observations of Vanoverschelde et al. (21) in patients with
dysfunctional collateral-dependent myocardium. They found
that rest blood flow was not significantly decreased but that
flow reserve was blunted. Myocardial hibernation was initially
considered a consequence of sustained hypoperfusion, but
there are now recent data (21–23) suggesting that at least part
of hibernation may be interpreted as a cumulative effect of
multiple episodes of myocardial stunning or as a state of
chronic stunning. Our observations demonstrate the coexist-
ence in the same patients of hibernating regions with preserved
F-18 FDG uptake, some with normal perfusion and others with
insufficient blood flow.
Significance of reduced regional F-18 FDG uptake. Mod-
erate reduction (from 50% to 75%) of F-18 FDG uptake was
found in 56 of 214 dyssynergic segments, and contractile
reserve was present in only 14 (25%), together with preserved
perfusion in the majority of corresponding segments. The
clinical significance of reduced myocardial glucose utilization
in regions with normal perfusion has been investigated in only
one study (10) in patients with chronic CAD. This pattern was
frequent: 65% of patients, with the majority of segments
exhibiting abnormal contractility at rest and inducible ischemia
during exercise. Perrone-Filardi et al. (10) speculated that
these regions represent an admixture of fibrotic and reversibly
ischemic myocardium. As an alternative explanation, they also
proposed that reperfused stunned myocardium may character-
ize regions with reduced F-18 FDG associated with preserved
perfusion. Stunned myocardium retains contractile reserve:
We found a low proportion of similar segments with contractile
reserve, thus failing to confirm the latter hypothesis proposed
by Perrone-Filardi et al. (10).
Contractile reserve in several myocardial states. A positive
inotropic response to catecholamine stimulation in dyssynergic
segments at baseline implies the preservation of some flow
reserve, together with at least partial myocyte integrity and
recruitable contractile material. On the basis of the findings of
the present investigation, it appears that the presence of
contractile reserve in patients with chronic CAD and severe
ventricular dysfunction is not specific for a single myocardial
state. Indeed, improvement in systolic thickening during low
dose dobutamine infusion was observed, albeit in different
proportions, in four of the six PET categories. A majority of
dyssynergic segments with “normal” PET findings, exhibited
contractile reserve; this pattern suggests the presence of myo-
cardial stunning. The absence of contractile reserve in a
significant proportion of segments with normal PET findings
may be explained by several factors: the low dobutamine dose
used in this study, mechanical forces such as tethering (24) or
beta-receptor downregulation in patients with heart failure.
Myocardial regions with increased F-18 FDG uptake rela-
tive to perfusion probably correspond to hibernating myocar-
dium. In this situation, basal preserved perfusion in some
segments and reduced perfusion in others probably represent
two different aspects of hibernation. Contractile reserve is
highly frequent when perfusion is normal at rest and glucose
utilization is enhanced, whereas it is observed in ,50% of
regions with abnormal perfusion. Such a relation between K-38
uptake and the proportion of segments with contractile re-
sponse to dobutamine is also found in regions with moderately
reduced F-18 FDG uptake, which have been thought to
represent an admixture of subendocardial necrosis and subepi-
cardial viable tissue (10). These findings are in agreement with
the results of Panza et al. (6) who demonstrated a relation
between the magnitude of thallium-201 uptake with SPECT
using a stress–redistribution–reinjection protocol and the ino-
tropic response to dobutamine with transesophageal echocar-
diography.
Among the segments with concordant decreases in both
perfusion and glucose utilization, suggesting irreversibly dam-
aged myocardium, improvement of thickening with dobut-
amine was found in 23%. Our results are in agreement with
those recently published by Sawada et al. (17), which showed
that 29% of segments classified nonviable by PET were viable
by dobutamine echocardiography. In patients with a previous
myocardial infarction, perfusion and glucose uptake may be
below normal limits in the absence of complete transmural
necrosis. We previously observed (25) residual contractile
reserve in some patients with a recent myocardial infarction
who exhibited this PET pattern. There is no other rational
explanation for this finding, which may also be related to
suboptimal anatomic correspondence between the two imaging
techniques, in some patients.
Limitations of the study. Several limitations should be
acknowledged: Only a limited number of our patients under-
went coronary artery bypass graft surgery. Consequently, we
cannot compare the relative ability of PET and dobutamine
echocardiography for predicting improvement of regional con-
tractility after revascularization. The respective proportion of
functional recovery in the different PET patterns cannot be
described.
We used only low dose dobutamine infusion at 5 and
10 mg/kg per min for detection of contractile reserve, which
represents the first (13) and most frequently used protocol
(4,26–28). Other investigators (29,30) have demonstrated the
usefulness of additional higher doses for optimal evaluation.
Recent experimental data (30) suggest that in the absence of
beta-blockers, 15 mg/kg per min is the optimal dobutamine
dose needed to elicit maximal thickening of stunned myocar-
dium. We could not identify a biphasic response with our
dobutamine protocol. This biphasic response has been shown
(29) to have the highest predictive value for recovery of
function after angioplasty. Although high dose dobutamine
echocardiography appears to be safe in patients with chronic
CAD, we preferred to avoid higher doses for safety reasons.
Worsening of function after earlier improvement indicates
ischemia and is included within the criteria for stopping the
dobutamine infusion. However, persistent akinesia does not
exclude the presence of viable myocardium, as shown by our
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results. In this case, maintenance of high dobutamine doses
may be deleterious, and myocardial ischemia may remain
undetected.
The assessment of contractile reserve was based on quali-
tative criteria. Quantitative measurement of systolic wall thick-
ening may provide more reliable information but is not yet
available in clinical practice. Application of quantitative meth-
ods is difficult; endocardial or epicardial dropout is frequent on
stop frame images; manual tracing of the endocardial and
epicardial contours involves a subjective component; and
assessment of end-diastolic and end-systolic images alone lacks
the visual integration of information throughout the cardiac
cycle and from multiple views.
Absolute myocardial blood flow and glucose utilization
were not calculated. However, it is not the rule to use absolute
values of flow and glucose utilization in a clinical setting.
Semiquantitative data analysis was performed, and a normal
data base was used to define normal limits. Fixed threshold
values used to define normality may represent too strict criteria
and may not reflect physiologic variability of myocardial per-
fusion or glucose utilization. However, this situation does not
affect the conclusions of the present analysis, which showed
that myocardial regions with different perfusion–metabolic
patterns may have a similar contractile response to dobut-
amine.
Finally, the assessment of myocardial contractility, perfu-
sion and glucose utilization was performed with two different
techniques. Although every effort was made to match the
echocardiographic and PET results, it is possible that misalign-
ment occurred to some extent and partially contributed to our
observations.
Conclusions. The present study shows fair concordance
between PET and dobutamine echocardiography for identifi-
cation of myocardial viability in most patients with chronic
ischemic left ventricular dysfunction. Our results indicate that
the interpretation of PET findings should not be restricted to
the three traditional patterns of normal, mismatch and necrotic
tissue. Myocardial regions exhibiting normal rest perfusion
have a different functional status, depending on the magnitude
of glucose utilization. Contractile reserve is observed with a
variable incidence in the presence of several PET patterns,
probably corresponding to different myocardial states. Most
segments exhibiting preserved perfusion and increased F-18
FDG uptake have impaired contractility at baseline, but
contractile reserve is present, suggesting the presence of
hibernating myocardium. The present study supports the
concept that myocardial hibernation is a heterogeneous
condition.
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